TITLE

Fampridine

PUB. DATE
January 2014
SOURCE
Reactions Weekly;1/11/2014, Issue 1483, p45
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents a case study of five multiple sclerosis patients who had positive neurologic phenomena and seizures after ingestion of dalfampridine to treat multiple sclerosis.
ACCESSION #
93626887

 

Related Articles

  • Mitoxantrone.  // Reactions Weekly;May2015, Vol. 1549 Issue 1, p180 

    The article presents a case study of eleven girls and two boys who developed various toxicities during the administration of mitoxantrone for multiple sclerosis.

  • Natalizumab.  // Reactions Weekly;Sep2014, Vol. 1517 Issue 1, p138 

    The article presents a case study of a 22-year-old woman who had aggressive multiple sclerosis (MS) exacerbation when using natalizumab to treat her MS.

  • Fampridine.  // Reactions Weekly;Nov2015, Vol. 1579 Issue 1, p187 

    The article describes the cases of patients who have multiple sclerosis who developed liver cholestasis concomitant to a urinary tract infection and flu-like symptoms after treatment with fampridine, referencing research by G. Cacao and colleagues, published in the "Multiple Sclerosis Journal."

  • Nabiximols.  // Reactions Weekly;Nov2015, Vol. 1579 Issue 1, p287 

    The article describes the case of a patient who had fall and fracture after application of nabiximols for multiple sclerosis spasticity, referencing research by P. Flachenecker and colleagues, published in the journal "European Neurology."

  • Dimethyl fumarate.  // Reactions Weekly;Nov2015, Vol. 1579 Issue 1, p153 

    The article describes the case of a patient who developed lowest lymphocyte count during treatment with dimethyl fumarate for multiple sclerosis, referencing research by N.J. MacDougal and colleagues, published in the "Multiple Sclerosis Journal."

  • Azelnidipine.  // Reactions Weekly;12/18/2010, Issue 1332, p12 

    The article describes the case of a 76-year-old man who presented with chyloperitoneum while receiving treatment with azelnidipine for hypertension, referencing a study published in the October 2010 issue of the journal "Clinical and Experimental Nephrology."

  • Ceftriaxone.  // Reactions Weekly;12/18/2010, Issue 1332, p14 

    The article describes case reports of four patients, who had end-stage renal disease, who experienced choreoathetosis while receiving treatment with ceftriaxone, referencing a study published in the November 2010 issue of the "American Journal of the Medical Sciences."

  • Adalimumab.  // Reactions Weekly;Aug2014, Vol. 1515 Issue 1, p17 

    The article presents a case study of a 36-year-old man developed multiple sclerosis while receiving adalimumab.

  • Adalimumab.  // Reactions Weekly;Sep2014, Vol. 1517 Issue 1, p19 

    The article presents a case study of a woman who developed multiple sclerosis following the administration of adalimumab.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics